Systemic effects of inflammation on health during chronic HIV infection.

[1]  L. Ferrucci,et al.  Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy , 2013, The Journal of experimental medicine.

[2]  B. Greenwood-Van Meerveld,et al.  Age-associated remodeling of the intestinal epithelial barrier. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  J. Lok,et al.  The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy , 2013, AIDS.

[4]  Rebecca Hoh,et al.  Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. , 2013, The Journal of infectious diseases.

[5]  Mardge H. Cohen,et al.  Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. , 2013, The Journal of infectious diseases.

[6]  Jeffrey N. Martin,et al.  AIDS Alters the Commensal Plasma Virome , 2013, Journal of Virology.

[7]  L. Kuller,et al.  HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation , 2013, Journal of the American Heart Association.

[8]  Ryan D. Hernandez,et al.  Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism , 2013, Science Translational Medicine.

[9]  J. Berger,et al.  Aspirin Attenuates Platelet Activation and Immune Activation in HIV-1-Infected Subjects on Antiretroviral Therapy: A Pilot Study , 2013, Journal of acquired immune deficiency syndromes.

[10]  Jeffrey N. Martin,et al.  Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. , 2013, The Journal of infectious diseases.

[11]  D. Douek,et al.  Immune activation and HIV persistence: implications for curative approaches to HIV infection , 2013, Immunological reviews.

[12]  B. Gazzard,et al.  The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study). , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Lederman,et al.  The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. , 2013, Blood.

[14]  L. Partridge,et al.  The Hallmarks of Aging , 2013, Cell.

[15]  C. Rouzioux,et al.  The Th17/Treg Ratio, IL-1RA and sCD14 Levels in Primary HIV Infection Predict the T-cell Activation Set Point in the Absence of Systemic Microbial Translocation , 2013, PLoS pathogens.

[16]  K. Brummel‐Ziedins.  Models for thrombin generation and risk of disease , 2013, Journal of thrombosis and haemostasis : JTH.

[17]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[18]  K. Kraemer,et al.  HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.

[19]  R. Krauss,et al.  Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013 .

[20]  S. Iliffe,et al.  Frailty in elderly people , 2013, The Lancet.

[21]  A. Oxenius,et al.  Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection , 2013, BMC Infectious Diseases.

[22]  D. Neau,et al.  Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. , 2013, The Journal of infectious diseases.

[23]  C. Deming,et al.  Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. , 2013, The Journal of clinical investigation.

[24]  B. Engelmann,et al.  Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.

[25]  O. Yang,et al.  Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. , 2012, The Journal of infectious diseases.

[26]  Larissa B. Thackray,et al.  Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome , 2012, Cell.

[27]  C. Longenecker,et al.  Elevated D-Dimer is Independently Associated with Endothelial Dysfunction: A Cross-Sectional Study in HIV-Infected Adults on Antiretroviral Therapy , 2012, Antiviral therapy.

[28]  L. Kuller,et al.  Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals , 2012, PloS one.

[29]  R. Ribeiro,et al.  Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. , 2012, Blood.

[30]  B. Gazzard,et al.  Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial. , 2012, JAMA.

[31]  K. Kraemer,et al.  HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  L. Kuller,et al.  Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Jerome J. Schentag,et al.  Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. , 2012, Surgery.

[34]  J. Qin,et al.  Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease , 2012, PloS one.

[35]  P. Massip,et al.  Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. , 2012, The Journal of clinical investigation.

[36]  A. Haase,et al.  Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy , 2012, PLoS pathogens.

[37]  S. Lewin,et al.  CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. , 2011, The Journal of infectious diseases.

[38]  S. Lewin,et al.  Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial. , 2011, The Journal of infectious diseases.

[39]  E. Rosenberg,et al.  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. , 2011, The Journal of infectious diseases.

[40]  D. Kleiner,et al.  Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. , 2011, Gastroenterology.

[41]  M. Clerici,et al.  Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. , 2011, Blood.

[42]  Natalie J Torok,et al.  Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations With Immune Activation , 2011, Journal of acquired immune deficiency syndromes.

[43]  A. d’Arminio Monforte,et al.  Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count , 2011, AIDS.

[44]  A. Rissanen,et al.  Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation , 2011, Diabetes Care.

[45]  P. Mannucci,et al.  The coagulopathy of chronic liver disease. , 2011, The New England journal of medicine.

[46]  Richard D Moore,et al.  Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients , 2011, PloS one.

[47]  E. Rosenberg,et al.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. , 2011, The Journal of infectious diseases.

[48]  A. Mocroft,et al.  Hyaluronic Acid Levels Predict Increased Risk of Non-Aids Death in Hepatitis-Coinfected Persons Interrupting Antiretroviral Therapy in the Smart Study , 2011, Antiviral therapy.

[49]  A. Newman,et al.  Inflammatory markers in population studies of aging , 2011, Ageing Research Reviews.

[50]  P. D. de Bakker,et al.  Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. , 2011, The Journal of clinical investigation.

[51]  D. Boulware,et al.  Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. , 2011, The Journal of infectious diseases.

[52]  E. Sinclair,et al.  Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. , 2011, The Journal of infectious diseases.

[53]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[54]  M. Clerici,et al.  Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial , 2011, Mucosal Immunology.

[55]  E. Aandahl,et al.  An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses , 2011, Journal of Virology.

[56]  J. Skinner,et al.  Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV , 2011, AIDS.

[57]  D. Follmann,et al.  High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. , 2011, The Journal of infectious diseases.

[58]  S. Lewin,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[59]  V. Salomaa,et al.  Endotoxemia Is Associated With an Increased Risk of Incident Diabetes , 2011, Diabetes Care.

[60]  A. Sadler,et al.  The role of protein kinase R in the interferon response. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[61]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[62]  A. Zolopa,et al.  Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort , 2010, Journal of acquired immune deficiency syndromes.

[63]  D. Duprez,et al.  Interleukin‐6 and d‐dimer levels are associated with vascular dysfunction in patients with untreated HIV infection , 2010, HIV medicine.

[64]  H. ten Cate,et al.  The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals , 2010, Thrombosis and Haemostasis.

[65]  Benjamin K. Chen,et al.  Human immunodeficiency virus (HIV)‐1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein‐1 expression: Implications for the pathogenesis of HIV/hepatitis C virus–induced liver fibrosis , 2010, Hepatology.

[66]  S. Pittaluga,et al.  Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections , 2010, PLoS pathogens.

[67]  S. Gange,et al.  Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study , 2010, AIDS.

[68]  V. Natarajan,et al.  Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection , 2010, AIDS.

[69]  D. Jacobs,et al.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.

[70]  Jeff E. Mold,et al.  Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.

[71]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[72]  A. Justice.  HIV and Aging: Time for a New Paradigm , 2010, Current HIV/AIDS reports.

[73]  M. Kuroda,et al.  Increased Monocyte Turnover from Bone Marrow Correlates with Severity of SIV Encephalitis and CD163 Levels in Plasma , 2010, PLoS pathogens.

[74]  Sarah Palmer,et al.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects , 2010, Nature Medicine.

[75]  Jeffrey N. Martin,et al.  Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease , 2010, PloS one.

[76]  M. Lederman,et al.  Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. , 2010, Blood.

[77]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[78]  H. Büller,et al.  The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. , 2009, AIDS patient care and STDs.

[79]  Richard D Moore,et al.  Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution , 2009, AIDS.

[80]  H. Lane,et al.  Interleukin-2 therapy in patients with HIV infection. , 2009, The New England journal of medicine.

[81]  M. King,et al.  Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. , 2009, The Journal of infectious diseases.

[82]  M. Kuroda,et al.  The level of monocyte turnover predicts disease progression in the macaque model of AIDS. , 2009, Blood.

[83]  B. Hirschel,et al.  HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial , 2009, AIDS.

[84]  J. Margolick,et al.  Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa , 2009, Proceedings of the National Academy of Sciences.

[85]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[86]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[87]  D. Douek,et al.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.

[88]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[89]  J. van der Meer,et al.  Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. , 2008, Clinical chemistry.

[90]  S. Ray,et al.  Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. , 2008, Gastroenterology.

[91]  Steven Wolinsky,et al.  Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients , 2008, PloS one.

[92]  M. Clerici,et al.  Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis , 2007, Journal of Clinical Microbiology.

[93]  J. Margolick,et al.  HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[94]  Yosuke Osawa,et al.  TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.

[95]  Gabriel Núñez,et al.  Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.

[96]  Michael D. George,et al.  Rapid Onset of Intestinal Epithelial Barrier Dysfunction in Primary Human Immunodeficiency Virus Infection Is Driven by an Imbalance between Immune Response and Mucosal Repair and Regeneration , 2007, Journal of Virology.

[97]  C. Franceschi,et al.  Cytomegalovirus Infection , 2007, Annals of the New York Academy of Sciences.

[98]  J. Herbeuval,et al.  HIV-1 immunopathogenesis: how good interferon turns bad. , 2007, Clinical immunology.

[99]  C. Caruso,et al.  Inflammatory networks in ageing, age-related diseases and longevity , 2007, Mechanisms of Ageing and Development.

[100]  M. Markowitz,et al.  Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection , 2006, PLoS medicine.

[101]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[102]  O. Kirk,et al.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.

[103]  L. Picker,et al.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.

[104]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[105]  C. Franceschi,et al.  Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity , 2005, FEBS letters.

[106]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[107]  K. Mann,et al.  Statins and Blood Coagulation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[108]  Christine Hogan,et al.  Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[109]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[110]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[111]  L. Meyer,et al.  CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection1 , 2004, The Journal of Immunology.

[112]  E. Frenkel,et al.  Thrombosis and a Hypercoagulable State in HIV-Infected Patients , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[113]  A. Justice,et al.  Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. , 2004, The American journal of medicine.

[114]  Tao Dong,et al.  Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.

[115]  S. Rubin,et al.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). , 2003, The American journal of cardiology.

[116]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[117]  A. Folsom,et al.  Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.

[118]  L. Fried,et al.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[119]  Steven Wolinsky,et al.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. , 2002, The Journal of clinical investigation.

[120]  G. Su,et al.  Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[121]  E. Burchardt,et al.  Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[122]  A. Sharrett,et al.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[123]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[124]  K. Mann,et al.  "Clotspeed," a mathematical simulation of the functional properties of prothrombinase. , 1984, The Journal of biological chemistry.

[125]  J. Turner,et al.  Endothelial and epithelial barriers in graft-versus-host disease. , 2012, Advances in experimental medicine and biology.

[126]  Amy C. Justice,et al.  HIV/AIDS, comorbidity, and alcohol: can we make a difference? , 2010 .

[127]  V. Salomaa,et al.  Spearman Rank Correlation Coefficients Between Serum Antibody Levels to Periodontal Pathogens , Endotoxin Concentration , and CVD Risk Factors in the Subcohort , 2007 .

[128]  R. Wood.  Combined antiretroviral therapy. , 1996 .

[129]  X. Causse,et al.  Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. , 1992, Journal of acquired immune deficiency syndromes.

[130]  L. Pasqualucci,et al.  Acute Myeloid Leukemia: Impact on Who Classification Mutated Nucleophosmin Detects Clonal Multilineage Involvement In , 2022 .